Myasthenia Gravis: Disease Overview Who: Bimodal distribution. Ages 20-40 (female predominance) and 50-70 (male predominance). Increased risk of onset in postpartum period; juvenile and congenital forms possible What: At the NMJ, Ach receptors are blocked by antibodies = decreased muscular contraction. Associated with fluctuating weakness. Home Treatments: Pyridostigmine (AchE inhibitor); +/- glucocorticoids, azathioprine, mycophenolate (immunosuppression) … Continue reading Myasthenic Crisis